Global View: Max Financial, Aurobindo Pharma, Bharti Airtel & Newgen Software could give 20-40% return

Indian market opened higher on Tuesday amid positive global cues as Nifty surpassed 17,300 and the Sensex added more than 200 points to its previous closing.There will be stock-specific action in which global brokerage came out with their reports on business development, or earnings outlook.

We have collated a list of recommendations from various global brokerage firms according to a Zee Business TV report:

Max Financial: Buy| Target Rs 1030

CLSA maintained buy rating on Max Financial with a target price of Rs 1030 that translates into an upside of over 46 per cent from Rs 703 recorded on 28 March.

See Zee Business Live TV Streaming Below:

The near-term headwinds could remain. The value of new business (VNB) margin is likely to remain steady. However, there are some challenges, but valuation remains cheap.

Aurobindo Pharma: Buy| Target Rs 845

BofA Securities maintained a buy rating on Aurobindo Pharma with a target price of Rs 845 that translates into an upside of nearly 20 per cent from Rs 707 recorded on 28 March.

Domestic acquisition provides a platform for the business to grow. Value unlocking in the injectable unit will be key triggers going forward. The deal is likely to provide near-term support to the stock.

Bharti Airtel: Outperform| Target Rs 900

Credit Suisse maintained an outperform rating on Bharti Airtel with a target price of Rs 900 that translates into an upside of over 22 per cent from Rs 733 recorded on 28 March.

The stock is well positioned to be one of leading integrated telcos in India. Airtel expects TAM for its emerging enterprise product offerings to post a 25% CAGR to Rs700bn by 2025.

The company has also revamped its strategy to go wider and deeper among its enterprise customers.

Newgen Software: Buy| Target Rs 650

Jefferies maintained a buy rating on Newgen Software but slashed its target price to Rs 650 from Rs 770 earlier. A target price cut still translates into an upside of over 30 per cent from Rs 482 recorded on 28 March.

In a recent meeting, CEO & CFO highlighted that Middle East & APAC region are doing well but the US is lagging due to high employee attrition at clients, which is delaying decision-making.

Revenues from SI-led engagements are also being delayed, said the note.

(Disclaimer: The views/suggestions/advices expressed here in this article is solely by investment experts. Zee Business suggests its readers to consult with their investment advisers before making any financial decision.)